As the clinical trial process continues its reign under the microscope of scrutiny, companies are starting to realise the true power of transparency – a weapon that can
Paula Mchale delves into the world of clinical trials and offers her expertise on how technology could enable better efficiency.
Mike Ackermann, Vice President of Global Commercial Strategy and Alliance at Quintiles, illuminates the significant barriers to successful biopharmaceutical commercialisation.
Amgen’s Madhavan Balachandran on why persistence is key to implementing an Operational Excellence campaign
Umetrics' Petter Mörée discusses the importance of process analytical technologies.